









Markets
/
Stocks
/
nasdaq-adgm
/

Adagio Medical Holdings Inc

ADGM

0.990USD

-0.020-1.98%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

15.23MMarket Cap

LossP/E TTM



Adagio Medical Holdings Inc

0.990

-0.020-1.98%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Adagio Medical Holdings Inc

Currency: USD Updated: 2026-02-06

Key Insights

Adagio Medical Holdings Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 123 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 4.00.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Adagio Medical Holdings Inc's Score

Industry at a Glance

Industry Ranking

123 / 205

Overall Ranking

321 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Adagio Medical Holdings Inc Highlights

StrengthsRisks

Adagio Medical Holdings, Inc. is a commercial stage medical device company. It is focused on developing proprietary Ultra-Low Temperature Cryoablation technology that creates contiguous, transmural lesions to treat cardiac arrhythmias, with an emphasis on ventricular tachycardia. It is developing and placing on the European Union (EU) market ablation technologies for the treatment of cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. Its product portfolio consists of three product families: iCLAS atrial ULTC catheter and accessories, vCLAS ventricular ULTC catheter, and Cryopulse atrial PFCA catheter and accessories. All of these catheters share the same ULTC cryoablation console. The iCLAS system is CE-marked with the indication for treatment of paroxysmal atrial fibrillation, persistent atrial fibrillation and atrial flutter. The vCLAS ventricular catheter has been specifically designed for the treatment of ventricular arrhythmia.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 218.52% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 602.00K.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 602.00K.

Overvalued

The company’s latest PE is -0.19, at a high 3-year percentile range.

Institutional Buying

The latest institutional holdings are 14.35M shares, increasing 14.80% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 79.45K shares of this stock.

Analyst Rating

Based on 1 analysts

Buy

Current Rating

4.000

Target Price

+288.35%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Adagio Medical Holdings Inc is 6.66, ranking 139 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 0.00, representing a year-over-year decrease of 100.00%, while its net profit experienced a year-over-year decrease of 118.58%.

Score

Industry at a Glance

Previous score

6.66

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.47

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

2.67

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

6.14

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.03

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Adagio Medical Holdings Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Adagio Medical Holdings Inc is 5.59, ranking 183 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.19, which is -100.00% below the recent high of 0.00 and -3084.17% above the recent low of -6.14.

Score

Industry at a Glance

Previous score

5.59

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 123/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Adagio Medical Holdings Inc is 8.00, ranking 60 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 4.00, with a high of 4.00 and a low of 4.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 1 analysts

Buy

Current Rating

4.000

Target Price

+288.35%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Adagio Medical Holdings Inc

ADGM

Boston Scientific Corp

BSX

Intuitive Surgical Inc

ISRG

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Adagio Medical Holdings Inc is 3.80, ranking 195 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 1.17 and the support level at 0.82, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

3.97

Change

-0.17

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(2)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.010

Buy

RSI(14)

50.168

Neutral

STOCH(KDJ)(9,3,3)

28.394

Sell

ATR(14)

0.092

High Vlolatility

CCI(14)

16.080

Neutral

Williams %R

57.143

Sell

TRIX(12,20)

0.195

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

1.016

Sell

MA10

1.011

Sell

MA20

0.969

Buy

MA50

0.969

Buy

MA100

1.208

Sell

MA200

1.282

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Perceptive Advisors LLC

9.88M

+0.00%

Sio Capital Management, LLC

1.29M

Adar1 Capital Management LLC

1.21M

Alyeska Master Fund LP

1.16M

Adage Capital Management, L.P.

1.06M

+28.89%

Usen (Todd)

662.46K

+45.55%

RTW Investments L.P.

209.36K

Mizuho Securities USA, LLC.

208.79K

-13.67%

Shaolin Capital Management, LLC

180.00K

-70.79%

Opaleye Management Inc.

110.57K

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Adagio Medical Holdings Inc is 1.46, ranking 191 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.12. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.